Tianda Pharmaceuticals Limited (0455.HK)
- Previous Close
0.255 - Open
0.265 - Bid 0.236 x --
- Ask 0.265 x --
- Day's Range
0.265 - 0.265 - 52 Week Range
0.173 - 0.280 - Volume
4,000 - Avg. Volume
394,949 - Market Cap (intraday)
569.761M - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.010 - Earnings Date --
- Forward Dividend & Yield 0.00 (1.02%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
--
Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It provides Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
www.tiandapharma.com863
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 0455.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0455.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0455.HK
Valuation Measures
Market Cap
548.26M
Enterprise Value
499.42M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.03
Price/Book (mrq)
0.93
Enterprise Value/Revenue
0.94
Enterprise Value/EBITDA
-24.07
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.54%
Return on Assets (ttm)
-1.81%
Return on Equity (ttm)
-4.01%
Revenue (ttm)
532.09M
Net Income Avi to Common (ttm)
-24.16M
Diluted EPS (ttm)
-0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
162.44M
Total Debt/Equity (mrq)
19.19%
Levered Free Cash Flow (ttm)
--
Company Insights: 0455.HK
0455.HK does not have Company Insights